Convallamarin
Appearance
Names | |
---|---|
IUPAC name
(22R)-27-(β-D-Galactopyranosyloxy)-3β-[β-D-glucopyranosyl-(1→4)-6-deoxy-β-D-gulopyranosyloxy]-22-hydroxy-5β-furost-25-en-1β-yl 6-deoxy-β-D-gulopyranosyl-(1→4)-6-deoxy-β-D-allopyranoside
| |
Systematic IUPAC name
(12S,13R,14S,15S,16R,32R,33R,34S,35R,36R,52R,54R,54aS,54bS,56aS,56bR,57S,58R,59aS,510aS,510bS,512aR,72R,73R,74S,75S,76R,92S,93R,94R,95R,96R)-16-(Hydroxymethyl)-36,54a,56a,57,76,96-hexamethyl-58-(3-methylidene-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)octadecahydro-51H-2,4,6,8-tetraoxa-5(2,4)-naphtho[2′,1′:4,5]indeno[2,1-b]furana-1,9(2),3(5,2),7(2,5)-tetrakis(oxana)nonaphane-13,14,15,33,34,58,73,74,93,94,95-undecol | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.014.298 |
EC Number |
|
PubChem CID
|
|
| |
| |
Properties | |
C57H94O27 | |
Molar mass | 1211.352 g·mol−1 |
Appearance | Yellowish-white crystalline powder |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Convallamarin[1] is a crystalline glycoside extracted from Convallaria majalis.[2]
References
[edit]- ^ "CONVALLAMARIN : MP Biomedicals". Archived from the original on 14 July 2011. Retrieved 21 July 2010.
- ^ "Materia Medica, General Therapeutics, and Pharmacy". The American Journal of the Medical Sciences. 57 (114): 527–528. April 1869.